Skip to content

Prospective randomized trial to evaluate a multimodal digital app in the treatment of erectile dysfunction

Prospective randomized trial to evaluate a multimodal digital app in the treatment of erectile dysfunction - EDDIG

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
DRKS
Registry ID
DRKS00029182
Enrollment
188
Registered
2022-06-01
Start date
2022-05-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N48.4

Interventions

Group 1: intervention: multimodal self-management via Kranus Edera App over a 12 week period Group 2: controll group: Patients on the waiting list for the app, no new treatments for 12 weeks

Sponsors

Kranus Health GmbH
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: IIEF = 21 in IIEF-5-questionnaire men over 18 years

Exclusion criteria

Exclusion criteria: Patients with serious cardiac risk factors (moderate to severe risk according to the Princeton classification) unstable or refractory angina pectoris, uncontrolled hypertension, congestive heart failure (NYHA class III-IV), high-risk arrhythmia (exercise-induced ventricular tachycardia, implanted internal cardioverter defibrillator with frequent shocks, and poorly controlled atrial fibrillation), obstructive hypertrophic cardiomyopathy with severe symptoms, and moderate to severe valve disease, particularly aortic stenosis) Patients with myocardial infarction within the last six months s/p. prostatectomy, radiation or seeds of the prostate s/p bigger surgery in the small pelvis with likelihood of nerval damage (eg rectal resection, cystectomy) nerval diseases (eg multiple sclerosis (MS), parkinson´s disease, apoplex, dementia, psychiatric diseases) s/p trauma to the pelvis/penile region/spine Active autoinjection therapy (SKAT, MUSE) Patients with orthopaedic conditions that do not allow to perform the extended pelvic floor exercises

Design outcomes

Primary

MeasureTime frame
primary endpoints: improvement of the IIEF score (erection score), improvement of qualiity of life (QoLMed questionnaire), improvement of patient activation (PAM13)

Secondary

MeasureTime frame
improvement of bloodpressure, BMI, hip-to-waist ratio

Countries

Germany

Contacts

Public ContactLaura Wiemer

Kranus Health GmbH

medical@kranushealth.com089 124 146 79

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026